BTT Shunt

Date
August 21, 2025
URL
https://x.com/WithAScalpel/status/1958499203082068443
Categories
Single VentricleTOFIntensive Care

The Blalock–Taussig–Thomas (BTT) Shunt

The Blalock–Taussig–Thomas shunt (BTT shunt) is a systemic-to-pulmonary artery connection that augments pulmonary blood flow in cyanotic congenital heart disease. First performed in 1944 for tetralogy of Fallot (TOF), it remains a foundational palliative strategy—now most often in its modified form using an interposition PTFE (Gore-Tex) graft between the subclavian/innominate artery and the pulmonary artery [1].

Goals and Physiological Rationale

  1. Increase Pulmonary Blood Flow (PBF) & Improve Oxygenation

    2. Provides a controlled additional source of PBF for lesions with limited antegrade pulmonary flow (e.g., TOF, pulmonary atresia, duct-dependent PBF), improving systemic oxyhemoglobin saturation.

  2. Promote Pulmonary Artery Growth

    3. Sustained, mildly elevated PA pressure/flow from the shunt can stimulate branch PA growth and remodeling—important for neonates/infants with hypoplastic PAs and for future surgical options. In selected infants, slightly larger grafts (e.g., 4 mm) have been associated with greater PA growth without higher complication rates [3].

  3. Augment Left-Heart Preload and Growth

    4. Increased pulmonary venous return enhances LA/LV filling, supporting LV growth in borderline LV size when a biventricular strategy is desired.

  4. Bridge to Definitive Repair

    5. Stabilizes oxygenation and allows somatic/PA growth prior to complete repair or staged palliation (e.g., TOF, PA/IVS, certain single-ventricle variants) [1].

Technical Considerations (Modified BTT)

  • Configuration: PTFE graft from subclavian or innominate artery to PA (usually ipsilateral branch PA). Side-to-end or end-to-side anastomoses are tailored to anatomy and surgeon preference [5].
  • Graft Size: Selected to balance oxygenation with the risk of overcirculation (common practice: 3.5–4.0 mm in neonates; larger infants may require 4–5 mm). Evidence suggests 4 mm can enhance PA growth in carefully selected neonates/infants [3].
  • Hemodynamic Balance: The aim is balanced Qp:Qs. Excess shunt flow can cause pulmonary overcirculation, LV volume overload, and heart failure; inadequate flow fails to improve oxygenation [1].
  • Monitoring/Access: When using the right subclavian/innominate artery, right radial arterial pressure may be affected by shunt runoff; assess upper-limb perfusion and choose monitoring sites accordingly.

Outcomes, Complications, and Surveillance

  • Outcomes over Eras: Large series across six decades confirm the BTT shunt’s durability as a palliative tool, with evolving indications as complete neonatal repair and catheter-based palliation expanded [2]. Contemporary series reaffirm its importance while highlighting careful patient selection and technique refinements [1].
  • Modified vs Classic: The modified BTT is the contemporary standard (better handling characteristics of PTFE; easier size control) and is widely favored over the classic subclavian-to-PA anastomosis. However, PA distortion and anastomotic stenosis remain recognized risks, particularly in neonates and with certain anastomotic geometries—necessitating vigilant imaging follow-up [5].
  • Complications to Anticipate:

    • – Early: shunt thrombosis/occlusion, bleeding, pulmonary overcirculation/heart failure.

    – Late: PA branch distortion/stenosis, graft stenosis, infection, differential arm perfusion (“steal”) if the subclavian artery is used.

  • PA Growth Signal: In neonates/infants, larger grafts (4 mm) have been associated with improved branch PA growth without excess adverse events when chosen judiciously [3].
  • Post-op Practice Points: Many centers employ antiplatelet therapy (e.g., low-dose aspirin) after mBTT to mitigate thrombotic risk; serial echocardiography and, when indicated, cross-sectional imaging guide timing of reintervention/conversion to next stage [1].

Contemporary Alternatives and Evolving Practice

  • Ductal (PDA) Stenting: For duct-dependent pulmonary blood flow, PDA stenting has emerged as a compelling alternative to surgical shunts in appropriate anatomy, with the appeal of shorter recovery and preserved surgical options; practice is increasingly shaped by institutional expertise and ductal morphology [2].
  • Global Context: In many regions—particularly resource-limited settings—the BTT shunt remains indispensable and relatively safe when applied thoughtfully, supporting survival to later definitive procedures [4].
  • Terminology: There is a growing movement to explicitly recognize Vivien Thomas’s central role by using “Blalock–Thomas–Taussig shunt.” Many journals now endorse or discuss this nomenclature change [6].
image

References

[1] McKenzie E, Khan MS, et al. The Blalock-Taussig shunt revisited: a contemporary experience. Journal of the American College of Surgeons. 2013. doi:10.1016/j.jamcollsurg.2013.04.016.

[2] Moore JW. PDA Stenting for Ductal-Dependent Cyanotic Congenital Heart Disease: An Overview. Pediatric Cardiology. 2024. doi:10.1007/s00246-024-03427-5.

[3] Abou Elella R, Umereta N, Alabari I, et al. The short- and long-term effect of Blalock-Taussig shunt size on pulmonary artery growth and complications in neonates and infants. Annals of Saudi Medicine. 2014. doi:10.5144/0256-4947.2014.494.

[4] Rana JS, Ahmad K, Shamim A, Hamad SB, et al. Blalock-Taussig shunt: experience from the developing world. Heart, Lung and Circulation. 2002. doi:10.1046/j.1444-2892.2002.00145.x.

[5] Yuan S-M. The Blalock-Taussig Shunt. Journal of Cardiac Surgery. 2009. doi:10.1111/j.1540-8191.2009.00859.x.

[6] Blake V, Yancy CW. Change the Name of the Blalock-Taussig Shunt to Blalock-Thomas-Taussig Shunt. JAMA Surgery. 2021. doi:10.1001/jamasurg.2021.2496.

[7] Gladman G, et al. The modified Blalock-Taussig shunt: clinical and angiographic results. Journal of Thoracic and Cardiovascular Surgery. 1997. doi:10.1016/S0022-5223(97)70145-1.

[8] Williams J, Bansal A, Kim BJ, et al. Two thousand Blalock-Taussig shunts: a six-decade experience. Annals of Thoracic Surgery. 2007. doi:10.1016/j.athoracsur.2006.10.046.